APPLICATION
ANDA208332
TYPE
ANDA
ORIGINAL APPROVAL
2017-06-12
LATEST ACTION
2024-04-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
EZETIMIBEDiscontinued
EZETIMIBE 10MG · TABLET · ORAL
Approval history
2024-04-15Labeling · Supplement 6 · standardAP
2023-10-17Labeling · Supplement 4 · standardAP
2017-06-12UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.